Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivascardiology

Paeds Vivas · cardiology

Duct-dependent congenital heart disease: Viva

Branching clinical structured oral on duct-dependent congenital heart disease: recognising a well baby collapsing on day 3 with cyanosis and shock, the two-pathway split, emergency prostaglandin E1 with its apnoea and pyrexia traps, and the pulse oximetry screening programme.

branching clinical structured oral3 min readVerification in progress

Target exams

RACP DWERACP DCEMRCPCH Clinical
On this page
Study tools

Target exams

RACP DWERACP DCEMRCPCH Clinical
Prompt
A 4-day-old girl is brought to the emergency department by her parents. She was discharged home on day 1 looking well and feeding normally. Over the last 6 hours she has become blue, floppy, and is breathing rapidly. On examination her saturation is 70% in air and does not improve when 100% oxygen is given. There is no murmur. The examiner asks for your structured approach.

Branch 1: Recognising the time-critical problem

The candidate should immediately recognise that this baby has cyanosis unresponsive to 100 percent oxygen in a neonate who was well at discharge and collapsed on day 4. This is the classic presentation of duct-dependent congenital heart disease, specifically a duct-dependent pulmonary circulation where blood cannot reach the lungs once the ductus arteriosus has closed. The saturation of 70 percent that does not improve with oxygen is the key discriminator from a pulmonary cause, and the absence of a murmur does not exclude critical congenital heart disease because many severe obstructive lesions generate no turbulent flow. [1]

The candidate should state that the single most urgent intervention is to start prostaglandin E1 (alprostadil) at 0.01 to 0.05 micrograms per kilogram per minute intravenously, without waiting for the echocardiogram. The rationale is that the closed ductus arteriosus was the only route for blood to reach the lungs, and reopening it restores pulmonary blood flow and improves the saturation. The first priorities are airway, breathing, and circulation, an intravenous line, and a bedside glucose, followed by the prostaglandin infusion moment suspicion is raised. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Silberbach M; Hannon D Presentation of congenital heart disease in the neonate and young infant. Pediatr Rev, 2007.PMID 17400823
  2. [2]Lewis AB; Freed MD; Heymann MA; Roach A; Rudolph AM Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation, 1981.PMID 7285304
  3. [3]Thangaratinam S; Brown K; Zamora J; et al Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet, 2012.PMID 22554860
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCyanotic newborn and critical congenital heart disease screening — branching vivacardiologyNextEbstein anomaly and tricuspid valve disease — branching vivacardiology